Valneva Announces Closing of Approximately $102.0 Million Global Offering
Saint-Herblain (France), November 3, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”),…
Month: November 2021
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021
GUANGZHOU, China, Nov. 03, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange
CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
Ocugen to Host Conference Call on Tuesday, November 9 at 8:30 a.m. ET to Discuss Third Quarter 2021 Financial Results and Provide Business Update
MALVERN, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
New Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presented at AASLD The Liver Meeting®
Lille, France; Cambridge, MA; November 02, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
Tarsus to Participate in the Virtual Credit Suisse 30th Annual Healthcare Conference
IRVINE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
Oncternal Therapeutics Announces Formation of Cell Therapy Scientific Advisory Board
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Oyster Point Pharma to Present Data at the American Academy of Optometry Annual Meeting 2021
PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Timber Pharmaceuticals Announces Proposed Public Offering
Basking Ridge, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc….
Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Aquestive Therapeutics Reports Third Quarter 2021 Financial Results, Provides Business Update and Improves Full Year Guidance
Libervant™ (diazepam) Buccal Film continues to progress through the FDA review process in advance of…
Entrada Therapeutics Announces Closing of Initial Public Offering
BOSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company…
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. On-going Phase 2b clinical…
Opiant Announces Publication of Manuscript Treatment of Overdose in the Synthetic Opioid Era in Peer-Reviewed Journal Pharmacology & Therapeutics
SANTA MONICA, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT),…
Calithera Biosciences to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a…
Agile Therapeutics Reports Third Quarter 2021 Financial Results
Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla…
Corvus Pharmaceuticals to Present Updated Mupadolimab (Anti-CD73) Data at 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Company to host conference and webcast on November 12, 2021 at 9:00 am ET /…
Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021
Conference Call and Webcast Scheduled for Tuesday, November 9, 2021 at 4:30 p.m. Eastern SAN…
Capricor Therapeutics to Present Third Quarter 2021 Financial Results and Recent Corporate Update on November 9
Company to Host Conference Call, November 9, 2021, at 4:30 p.m. ET LOS ANGELES, Nov….
PacBio Announces Third Quarter 2021 Financial Results
MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial…